Increase in serum IL-4 in response to venetoclax therapy in xenograft models of acute myeloid leukaemia
Despite significant progress in basic and preclinical research into acute myeloid leukaemia (AML), the five-year survival rate for patients with AML remains poor, highlighting the urgent need for new combination therapies. Over the past decade, increased attention has been focused on identifying sui...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado em: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2024-07-01
|
| Colecção: | Медицинская иммунология |
| Assuntos: | |
| Acesso em linha: | https://www.mimmun.ru/mimmun/article/view/3056 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|